The International Finance Corporation mobilizes private capital at scale, supports businesses from microenterprises to large corporations, and creates jobs that drive economic growth and reduce ...

Canada has approved an Indian pharma company’s generic version of the anti-diabetes drug Ozempic, for use in the country. Satish Reddy, managing director and chief operating officer of Dr Reddy's ...

The era of cheap, officially approved semaglutide is finally here—in Canada, that is. The country has just become the first in North America and the first G7 nation to license a generic version of the ...

Abstract: This study presents a Python-based framework for converting IFC data into RDF triples, ensuring semantic integrity and interoperability in BIM environments. Using the SemanIFC library for ...

Generic dapagliflozin is indicated to lower heart failure hospitalization risk in type 2 diabetes with established cardiovascular disease or multiple risk factors, and to improve glycemic control ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions. By Rebecca ...

The drug product from Cronus Pharma is indicated to control pain and inflammation associated with surgery in companion animals. Officials with the FDA have approvedthe first generic robenacoxib ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. The calls came over the span of a single month in 2004, ...

Abstract: The increasing use of Building Information Modeling (BIM) in design and construction practices has emphasized the need for structured and replicable data extraction methods. This study ...

Forbes contributors publish independent expert analyses and insights. The U.S. spent $722.5 billion on pharmaceuticals in 2023. Although brand-name drugs consume four out of every 5 dollars America ...